𝔖 Bobbio Scriptorium

✦ LIBER ✦

Sustained response rates of chronic hepatitis C patients treated with interferon alpha with doses tailored to pre-treatment HCV RNA levels: A prospective randomized pilot study

✍ Scribed by Freilich, BL; Eisenach, JB; Raines, J; Jackson, L; VanOmmeren, T; Cornish, K

Book ID: 122689773
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 203 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)85037-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Higher doses of peginterferon alpha-2b a

Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study

✍ F. Lodato; F. Azzaroli; S. Brillanti; A. Colecchia; M. R. Tamé; M. Montagnani; R 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Rapid clearance of hepatitis C virus RNA

Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment

✍ K. Peerlinck; M. Willems; L. Sheng; F. Nevens; J. Fevery; S. H. Yap; J. Vermylen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

457 Retreatment with pegylated interfero

457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

✍ C. Bapin; P. Fabbro-Peray; S. Hachemane; F. Blanc; D. Diaz; P. Pueyo; D. Larrey 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Low dose of interferon can induce high r

Low dose of interferon can induce high rate of sustained complete response in chronic hepatitis C with low serum HCV RNA level: Results of a randomized controlled trial 1) Second Dpt of Internal Medicine, Osaka University Medical School1), Ikeda Municipal Hospital2), Osaka, Japan

📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB